Pfizer will end development of weight-loss pill over fears about its impact to the liver
The move comes after a patient in a trial suffered a liver injury potentially caused by the oral GLP-1 drug known as danuglipron.
The patient, who was not identified, did not experience any symptoms and their injury 'resolved' after they stopped taking the drug.
'While we are disappointed to discontinue the development of danuglipron, we remain committed to evaluating and advancing promising programs in an effort to bring innovative new medicines to patients,' Pfizer's Chief Scientific Officer Dr. Chris Boshoff said in a statement.
The Swiss company reviewed all clinical data for danuglipron and recent input for regulators before making their decision.
Its statement also suggested the patient's liver enzymes were elevated. That often is indicative of damage to cells in the organ, according to the Cleveland Clinic. Pfizer told CNBC that the trial rapidly increased the dose of the pill over a short span of time.
The company had previously scrapped the development of a twice-daily version of the drug in 2023 after trial patients experienced vomiting and nausea.
A once-daily pill could have had a competitive edge over other weight loss drugs taken twice a day.
Several companies are developing weight loss pills after surging popularity of the shots that target an intestinal hormone called GLP-1. Ozempic and Wegoy are popular injectables related to CLP-1. Oral drugs are also considered to be easier to make than injectables, as well as easier to take.
Obesity is a serious and common chronic disease. In the U.S. more than two in five adults have obesity.
The investment bank Morgan Stanley said the global market for obesity drugs is expected to reach $105 billion by 2030 — and as high as $144 billion. Comparatively, it noted that sales of branded obesity drugs had totaled $6 billion in 2023.
Pfizer said that it would continue development of an experimental oral drug targeting a different hormone.
'Cardiovascular and metabolic diseases including obesity remain important areas of unmet medical need, and we plan to continue applying our global capabilities to advance a pipeline of investigational treatments that have the potential to fill critical gaps in patient care, including continued development of our oral GIPR antagonist candidate and other earlier obesity programs,' he added.
With reporting from The Associated Press
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hill
an hour ago
- The Hill
Huge cuts to mRNA research spark fears about future pandemics
Health Secretary Robert F. Kennedy Jr.'s decision this week to cancel hundreds of millions of dollars in mRNA vaccine funding will leave the United States unprepared for the next pandemic and other public health emergencies, public health experts warned. 'I've tried to be objective & non-alarmist in response to current HHS actions—but quite frankly this move is going to cost lives,' President Trump's former surgeon general Jerome Adams said in a post to X. 'mRNA technology has uses that go far beyond vaccines… and the vaccine they helped develop in record time is credited with saving millions.' The first COVID-19 mRNA vaccines from Pfizer and Moderna hit the market in 2021, just a year after the virus first appeared. Vaccines typically take years to develop, but the mRNA shots were developed in record time due to a massive influx of funding from the first Trump administration, dubbed Operation Warp Speed. The COVID shots proved safe and effective, and helped bring about an end to the pandemic. Experts say mRNA technology has the potential to revolutionize treatments for evolving pathogens, especially bird flu, because the platform can be easily modified. On Tuesday, Kennedy cancelled $500 million worth of contracts related to mRNA vaccine research being funded by the Biomedical Advanced Research and Development Authority. Instead, he said the agency will focus on platforms with 'stronger safety records.' Public health experts point out that reviews of the hundreds of millions, if not billions, of doses of mRNA shots administered worldwide have found very few adverse events. 'It's pretty clear that the administration, or at least the secretary, has a political vendetta not just against vaccines but against mRNA in general,' said Jeff Coller, a professor of RNA biology and therapeutics at Johns Hopkins University. Coller said the move will put the U.S. behind other nations in biomedical research and sends a 'clear message' to scientists and the industry that it is not wise to invest in mRNA technology because if they do, they will likely not receive funding or approval from the federal government. Jennifer Nuzzo, a professor of epidemiology and director of the Pandemic Center at Brown University School of Public Health, told The Hill that the cancellation is a threat to national security, as it opens the U.S. to future public health emergencies caused by biological warfare. 'One of the ways that we deter that from happening is to say the United States is absolutely committed to preparedness,' Nuzzo said. 'When we take them off the table and leave nothing in their place, we basically signal to our adversaries that we are no longer interested in defending ourselves.' In the long run, Nuzzo said, winding down research efforts on mRNA vaccine platforms will stifle medical innovation coming out of the U.S., including new treatments for diseases like cancer. 'It's troubling on a number of fronts,' she said. MRNA vaccines work by sending instructions to cells to make a specific type of protein found on the outer membrane of a virus. The body's immune system is then able to recognize that protein as something foreign and will create antibodies to fight it. That same general approach could be used to help potentially vaccinate someone against a particular cancer, according to Nuzzo. 'Cancers have a genetic signature,' she said. 'We don't know what's going to happen but there are some preliminary studies that suggest it could be a very promising way to treat cancers.' None of the canceled contracts directly deal with cancer research, but the move will likely cause a chilling effect among researchers that ultimately impacts cancer-related work, said Michael Osterholm, founding director of the Center for Infectious Disease Research and Policy and member of the Vaccine Integrity Project. 'I think you're going to see anyone who is willing to invest in mRNA technology, pulling back, if not completely, getting out of this business,' he said. 'This is terribly unfortunate, given that we have a number of other infectious diseases for which this vaccine platform was being explored in terms of taking on other infectious diseases and including some cancer vaccines.' Kennedy is deeply skeptical of vaccines in general, and mRNA vaccines in particular. In 2021, he falsely said the mRNA COVID-19 vaccine was the 'deadliest vaccine ever made.' Kennedy has also been facing pressure from fellow anti-vaccine activists for not doing enough to keep mRNA vaccines off the market. He was criticized earlier this year when the Food and Drug Administration approved Moderna's updated COVID-19 vaccine, even though the agency limited its use in children. In a video posted to X on Tuesday, Kennedy falsely claimed mRNA shots don't protect against respiratory viruses and don't work if a virus mutates. 'One mutation and the vaccine becomes ineffective,' Kennedy said. Following the announcement, public health experts urged Congress to restore funding towards mRNA vaccine research, with some calling it an 'assault' on federal vaccine policy. 'The HHS Secretary continues a mindless assault on sound federal vaccine policy,' said Robert Steinbrook, director of the Public Citizen Health Reseach Group. 'The mRNA vaccine platform was essential to rapid vaccine development and deployment during the COVIVD-19 pandemic and remains essential to preparing for future public health emergencies.' But the full extent of Kennedy's move isn't known. A Moderna spokesperson told The Hill that they were not aware of any new award cancellations since their contract to help develop an H5N1 bird flu vaccine was canceled in May. Gritstone Bio, another company on the HHS list of cancelled contracts, ceased operations earlier this year after the company filed for bankruptcy in 2024. A spokesperson for Tiba Bio said HHS's decision to terminate their BARDA contract 'comes as a surprise' since its contract was for a therapeutic, not a vaccine, and it does not use mRNA technology. Instead, it uses a method called RNA interference, which the FDA approved to treat some diseases in 2018.
Yahoo
an hour ago
- Yahoo
The Silent Symptom of Poor Gut Health That Most People Miss
The Silent Symptom of Poor Gut Health That Most People Miss originally appeared on Parade. You may be too tired to get through your day, have a general lack of energy, struggle to concentrate or just feel blah most of the time. Fatigue is relatively common, and it can be caused by a number of lifestyle habits or health issues. Poor gut health may be a contributing factor to fatigue. However, experts are still working to understand the exact relationship, explains , a gastroenterologist and chief of endoscopy at NYC Health + Hospitals/Bellevue. 'The science is still very much evolving.' Fatigue refers to 'extreme tiredness,' and may encompass trouble concentrating, a lack of motivation, depression, low energy, anxiety and weakness, according to the Cleveland Clinic. About 13.5% of American adults said they feel 'very tired or exhausted' most days, according to a 2022 National Center for Health Statistics survey. Here's what doctors want you to know about fatigue and gut health, and when to see a doctor. 🩺SIGN UP for tips to stay healthy & fit with the top moves, clean eats, health trends & more delivered right to your inbox twice a week💊 The Symptom of Poor Gut Health That's Often Missed Some studies have connected dysbiosis, or an imbalance in your gut microbiome, with certain types of fatigue, Dr. de Latour says. Researchers have also found differences in the gut microbiomes of people with chronic fatigue syndrome compared to people who don't have the condition. 'Gut health is closely tied to energy regulation,' says Dr. Aubrey Grant, MD, a sports cardiologist at MedStar Health in Washington, D.C. And it's likely a two-way relationship. Related: The 3 Most Important Things Your Poop Reveals About Your Health, According to Gastroenterologists The gut microbiome influences inflammation, nutrient absorption and neurotransmitter production, he explains. 'Dysbiosis can lead to systemic inflammation, altered metabolism and disruptions in serotonin and dopamine pathways, all of which contribute to fatigue.' Probiotics (like yogurt) and anti-inflammatory foods (such as fruits and vegetables) are good for your gut microbiome and are also known to boost energy, Dr. de Latour says. So if you don't typically eat these items, you might feel fatigued. Gut Health Conditions That May Cause Fatigue If your fatigue is linked to gut health, you'll likely experience other symptoms, too, Dr. Grant says. These may include bloating, abdominal pain, constipation, diarrhea, appetite changes, unexplained weight loss, nausea or bloody stool. Many conditions can cause fatigue, but Dr. de Latour says an important one to note is anemia, which is when you have low levels of red blood cells, and your body isn't making enough new blood cells normally. Related: The #1 Habit to Help You Poop Better When anemia is caused by iron deficiency, she says, 'We worry about small amounts of invisible blood loss from a tumor or large polyp in the gastrointestinal tract.' In these instances, Dr. de Latour says doctors may do an endoscopy procedure to examine your GI tract. Conditions like celiac disease can lead to iron-deficiency anemia because it causes small bowel inflammation, impacting your ability to absorb iron, she explains. Inflammatory bowel disease may also cause anemia. Irritable bowel syndrome, chronic gastritis and small intestinal bacterial overgrowth (SIBO) may also cause fatigue due to nutrient malabsorption, chronic inflammation or immune system activation, Dr. Grant says. When to See a Doctor If you're dealing with fatigue and worry it may be related to your gut health, Dr. de Latour says there are some other 'red flags' to watch for, including iron-deficiency anemia, blood in your stool, changes in your bowel habits or stool and weight loss. It's especially crucial to note these symptoms if you have a family history of colon cancer, she adds. Related: You Should Never Sit for More Than This Many Minutes When You're Pooping When you're experiencing fatigue that persists beyond a couple of weeks and any of these other symptoms, see your doctor, Dr. Grant says. They'll likely do blood work and possibly an endoscopy to identify any issues in your GI tract, Dr. de Latour says. Up Next: Sources: Rabia de Latour, MD, a gastroenterologist and chief of endoscopy at NYC Health + Hospitals/Bellevue Aubrey Grant, MD, a sports cardiologist at MedStar Health in Washington, D.C. Fatigue, Cleveland Clinic QuickStats: Percentage* of Adults Aged ≥18 Years Who Felt Very Tired or Exhausted Most Days or Every Day in the Past 3 Months,† by Sex and Age Group — National Health Interview Survey,§ United States, 2022, Centers for Disease Control and Prevention Gut Microbiota Dysbiosis: Triggers, Consequences, Diagnostic and Therapeutic Options, Microorganisms Studies find that microbiome changes may be a signature for ME/CFS, National Institutes of Health The Silent Symptom of Poor Gut Health That Most People Miss first appeared on Parade on Aug 6, 2025 This story was originally reported by Parade on Aug 6, 2025, where it first appeared.
Business Upturn
3 hours ago
- Business Upturn
Robert F. Kennedy Jr. cancels $500 million in mRNA vaccine projects
By Bhavya Rai Published on August 6, 2025, 14:39 EDT Health Secretary Robert F. Kennedy Jr. has announced that the government will cancel $500 million worth of vaccine development projects. These projects were based on mRNA technology, the same kind used in COVID-19 vaccines by Pfizer and Moderna. Kennedy said this decision came after a full review of the science and discussions with top health experts. Kennedy explained that the Department of Health and Human Services believes mRNA vaccines bring more risks than benefits, especially for diseases like COVID-19 and the flu. He shared the news in a video on the social media platform X. Kennedy has long been critical of vaccines, so this move was not a surprise to many. The cancellation affects 22 different projects. Major pharmaceutical companies like Pfizer, Sanofi, and CSL Seqirus will lose funding. Some universities, including Emory and Tiba Biotech, will also have their projects stopped. Only a few projects in their final stages will be allowed to finish. Many health experts are worried about this decision. Rick Bright, a former government vaccine expert, said it's a big mistake. He believes cutting mRNA research makes the country less prepared for future pandemics. He also said the decision could harm national security. The government also said that BARDA, the agency that supports vaccine research, will stop funding any new mRNA projects. Instead, they will invest in other vaccine types, such as whole-virus vaccines or newer methods. Some mRNA work in other areas of medicine may still continue. This is a major change in how the U.S. handles vaccine research. Many people are now wondering what this means for the future of pandemic response and public health.
